找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanotheranostics for Cancer Applications; Prakash Rai,Stephanie A. Morris Book 2019 This is a U.S. government work and not under copyright

[復制鏈接]
查看: 43520|回復: 57
樓主
發(fā)表于 2025-3-21 17:16:24 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Nanotheranostics for Cancer Applications
編輯Prakash Rai,Stephanie A. Morris
視頻videohttp://file.papertrans.cn/662/661148/661148.mp4
概述Provides a comprehensive review of cancer nanotheranostics.Represents the first book-length treatment of the topic.Presents a full picture of the field, from basic research through clinical implementa
叢書名稱Bioanalysis
圖書封面Titlebook: Nanotheranostics for Cancer Applications;  Prakash Rai,Stephanie A. Morris Book 2019 This is a U.S. government work and not under copyright
描述.This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field...Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotelytriggered drug delivery systems to limit cytotoxicity in the diseased area...This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the
出版日期Book 2019
關鍵詞Cancer Diagnostics; Cancer Nanotechnology; Cancer Nanotechnology Case Study; Drug Delivery Cancer; Drug
版次1
doihttps://doi.org/10.1007/978-3-030-01775-0
isbn_ebook978-3-030-01775-0Series ISSN 2364-1118 Series E-ISSN 2364-1126
issn_series 2364-1118
copyrightThis is a U.S. government work and not under copyright protection in the U.S.; foreign copyright pro
The information of publication is updating

書目名稱Nanotheranostics for Cancer Applications影響因子(影響力)




書目名稱Nanotheranostics for Cancer Applications影響因子(影響力)學科排名




書目名稱Nanotheranostics for Cancer Applications網(wǎng)絡公開度




書目名稱Nanotheranostics for Cancer Applications網(wǎng)絡公開度學科排名




書目名稱Nanotheranostics for Cancer Applications被引頻次




書目名稱Nanotheranostics for Cancer Applications被引頻次學科排名




書目名稱Nanotheranostics for Cancer Applications年度引用




書目名稱Nanotheranostics for Cancer Applications年度引用學科排名




書目名稱Nanotheranostics for Cancer Applications讀者反饋




書目名稱Nanotheranostics for Cancer Applications讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:36:13 | 只看該作者
Biological Events and Barriers to Effective Delivery of Cancer Therapeuticsractions between tumor cells and their microenvironment. The genetic and epigenetic abnormalities lead to the selective growth of tumor cells that are highly resistant to apoptotic cell death and capable of avoiding immune surveillance. Those aggressive biological characteristics contribute to intri
板凳
發(fā)表于 2025-3-22 02:48:50 | 只看該作者
Cancer Diagnostics and Therapeutics approaches have been initiated and developed resulting in the approval of a significant number of new drugs for the treatment of various cancers and better and improved treatment options, leading to longer survival and better quality of life for the large number of patients diagnosed with the disea
地板
發(fā)表于 2025-3-22 06:50:52 | 只看該作者
Nanomedicine in Cancerasses of nanoparticles are first described to detail the origin of their useful emergent properties in the context of current needs in cancer medicine and standard clinical practices. Specific applications focus on cancer therapeutics, cancer imaging, and in vitro diagnostics. In particular, this ch
5#
發(fā)表于 2025-3-22 11:42:10 | 只看該作者
6#
發(fā)表于 2025-3-22 15:32:02 | 只看該作者
7#
發(fā)表于 2025-3-22 18:26:58 | 只看該作者
8#
發(fā)表于 2025-3-23 00:32:04 | 只看該作者
9#
發(fā)表于 2025-3-23 05:04:29 | 只看該作者
Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulationsl for easily accessible, oral chemotherapy. A growing consensus points to nanoscale drug delivery systems as a promising therapeutic modality with enhanced efficacy and diminished side effects and with increasing evidence that these platforms can be engineered to facilitate transport of poorly bioav
10#
發(fā)表于 2025-3-23 05:50:09 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 21:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
沿河| 金门县| 南和县| 托克逊县| 日土县| 富蕴县| 大同县| 湖南省| 西平县| 含山县| 鄄城县| 齐河县| 余干县| 霍林郭勒市| 通海县| 中山市| 惠安县| 克什克腾旗| 宁波市| 富川| 郴州市| 怀柔区| 铜梁县| 浦城县| 安龙县| 石城县| 荥经县| 涞水县| 苏尼特左旗| 板桥市| 汪清县| 清镇市| 疏勒县| 阜南县| 蓬溪县| 兰州市| 财经| 肇东市| 屯留县| 黑龙江省| 高平市|